Vall d´hebron University Hospital

Barcelona 8035

8 studies enrolling now · 43 studies all time

What they study most

ARDS, Achondroplasia, Acute Decompensated Heart Failure, Adenovirus Infections, Advanced Cancers, Advanced Solid Tumor, Brain and Central Nervous System Tumors, Breast Cancer, Breast Neoplasms, Breast Neoplasms, Hormone Receptor Positive/HER2 Negative, Breast Neoplasms, Triple-Negative, Carcinoma, Non-Small-Cell Lung

Studies at this site

• A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT — Recruiting now
• A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors — Recruiting now
• SNV1521 in Participants With Advanced Solid Tumors — Recruiting now
• WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment) — Recruiting now
• Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19) — Recruiting now
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Recruiting now
• A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) — Recruiting now
• Accelerated Flap Coverage in Severe Lower Extremity Trauma — Recruiting now
• Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients — Running, not enrolling
• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors — Running, not enrolling
• Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype — Stopped early
• RegoNivo vs Standard of Care Chemotherapy in AGOC — Completed
• A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01) — Running, not enrolling
• Minimally Displaced Femoral Neck Fracture Pilot Study — Running, not enrolling
• A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease — Running, not enrolling
• Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) — Completed
• An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer — NO_LONGER_AVAILABLE
• LITMUS Imaging Study — Running, not enrolling
• Study of Cemiplimab in Adults With Cervical Cancer — Completed
• Safety of Pregnancy in BRCA Mutated Breast Cancer Patients — Completed
• Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia. — Stopped early
• ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study — Completed
• A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer — Stopped early
• Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer — Completed
• A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation — Completed
• Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures — Completed
• Selinexor in Advanced Liposarcoma — Completed
• Rational Therapeutics Based on Matched Tumor and Normal Tissue — Completed
• Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) — Stopped early
• Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST — Status unconfirmed
• Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease — Stopped early
• Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations — Stopped early
• The TAPS Trial - Fetoscopic Laser Surgery for Twin Anemia Polycythemia Sequence — Status unconfirmed
• Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer — Completed
• Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer — Completed
• Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III — Completed
• Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer — Completed
• A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint — Status unconfirmed
• Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III — Completed
• Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma — Stopped early
• Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer — Completed
• Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury — Completed